After outperforming broader market averages late last week, biotech stocks gave back some of their comparative gains on Monday. The Centient Biotech 200™ lost 12.37 points today, about .36% of its value, while broader indexes were mixed.
After outperforming broader market averages late last week, biotech stocks gave back some of their comparative gains on Monday. The Centient Biotech 200™ lost 12.37 points today, about .36% of its value, while broader indexes were mixed.